{"id":"https://openalex.org/W2911547717","doi":"https://doi.org/10.1158/1535-7163.mct-18-0831","title":"First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors","display_name":"First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors","alternate_titles":[],"publication_year":2019,"publication_date":"2019-03-01","ids":{"openalex":"https://openalex.org/W2911547717","doi":"https://doi.org/10.1158/1535-7163.mct-18-0831","mag":"2911547717","pmid":"https://pubmed.ncbi.nlm.nih.gov/30679388"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-18-0831","doi":"https://doi.org/10.1158/1535-7163.mct-18-0831","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-18-0831","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2911547717"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017930409","display_name":"Akihiko Shimomura","orcid":"https://orcid.org/0000-0002-2557-8170","observed_orcids":["https://orcid.org/0000-0002-2557-8170"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Akihiko Shimomura","raw_affiliation_strings":["1Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan","2Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]},{"raw_affiliation_string":"2Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030587345","display_name":"Noboru Yamamoto","orcid":"https://orcid.org/0000-0002-0787-2851","observed_orcids":["https://orcid.org/0000-0002-0787-2851"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Noboru Yamamoto","raw_affiliation_strings":["1Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan","3Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0000-0002-0787-2851","affiliations":[{"raw_affiliation_string":"1Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]},{"raw_affiliation_string":"3Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080299485","display_name":"Shunsuke Kondo","orcid":"https://orcid.org/0000-0001-9565-117X","observed_orcids":["https://orcid.org/0000-0001-9565-117X"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shunsuke Kondo","raw_affiliation_strings":["1Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061760818","display_name":"Yutaka Fujiwara","orcid":"https://orcid.org/0000-0001-6981-0800","observed_orcids":["https://orcid.org/0000-0001-6981-0800"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yutaka Fujiwara","raw_affiliation_strings":["1Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan","3Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0000-0001-6981-0800","affiliations":[{"raw_affiliation_string":"1Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]},{"raw_affiliation_string":"3Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058997514","display_name":"Shigenobu Suzuki","orcid":"https://orcid.org/0000-0002-8311-2045","observed_orcids":["https://orcid.org/0000-0002-8311-2045"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shigenobu Suzuki","raw_affiliation_strings":["4Department of Ophthalmic Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Ophthalmic Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014758837","display_name":"Noriko Yanagitani","orcid":"https://orcid.org/0009-0000-9922-1214","observed_orcids":["https://orcid.org/0009-0000-9922-1214"]},"institutions":[{"id":"https://openalex.org/I4210137039","display_name":"The Cancer Institute Hospital","ror":"https://ror.org/03md8p445","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137039"]},{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Noriko Yanagitani","raw_affiliation_strings":["5Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan","institution_ids":["https://openalex.org/I4210137039","https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045832805","display_name":"Atsushi Horiike","orcid":"https://orcid.org/0000-0002-1632-3125","observed_orcids":["https://orcid.org/0000-0002-1632-3125"]},"institutions":[{"id":"https://openalex.org/I4210137039","display_name":"The Cancer Institute Hospital","ror":"https://ror.org/03md8p445","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137039"]},{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Atsushi Horiike","raw_affiliation_strings":["5Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan","institution_ids":["https://openalex.org/I4210137039","https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056703048","display_name":"Satoru Kitazono","orcid":"https://orcid.org/0000-0001-7371-2787","observed_orcids":["https://orcid.org/0000-0001-7371-2787"]},"institutions":[{"id":"https://openalex.org/I4210137039","display_name":"The Cancer Institute Hospital","ror":"https://ror.org/03md8p445","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137039"]},{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Satoru Kitazono","raw_affiliation_strings":["5Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0000-0001-7371-2787","affiliations":[{"raw_affiliation_string":"5Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan","institution_ids":["https://openalex.org/I4210137039","https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003504724","display_name":"Fumiyoshi Ohyanagi","orcid":"https://orcid.org/0000-0002-8540-3452","observed_orcids":["https://orcid.org/0000-0002-8540-3452"]},"institutions":[{"id":"https://openalex.org/I4210137039","display_name":"The Cancer Institute Hospital","ror":"https://ror.org/03md8p445","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137039"]},{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fumiyoshi Ohyanagi","raw_affiliation_strings":["5Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan","institution_ids":["https://openalex.org/I4210137039","https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001115937","display_name":"Toshihiko Doi","orcid":"https://orcid.org/0000-0003-2042-6829","observed_orcids":["https://orcid.org/0000-0003-2042-6829"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Toshihiko Doi","raw_affiliation_strings":["6Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan","7Department of Experimental Therapeutics, National Cancer Center Hospital East, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan","institution_ids":["https://openalex.org/I4210145079"]},{"raw_affiliation_string":"7Department of Experimental Therapeutics, National Cancer Center Hospital East, Chiba, Japan","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060366426","display_name":"Yasutoshi Kuboki","orcid":"https://orcid.org/0000-0003-3675-953X","observed_orcids":["https://orcid.org/0000-0003-3675-953X"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasutoshi Kuboki","raw_affiliation_strings":["6Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063648563","display_name":"Akihito Kawazoe","orcid":"https://orcid.org/0000-0001-8632-3748","observed_orcids":["https://orcid.org/0000-0001-8632-3748"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Akihito Kawazoe","raw_affiliation_strings":["6Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015799240","display_name":"Kohei Shitara","orcid":"https://orcid.org/0000-0001-5196-3630","observed_orcids":["https://orcid.org/0000-0001-5196-3630"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kohei Shitara","raw_affiliation_strings":["6Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064282637","display_name":"Izumi Ohno","orcid":"https://orcid.org/0000-0001-6434-6797","observed_orcids":["https://orcid.org/0000-0001-6434-6797"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Izumi Ohno","raw_affiliation_strings":["8Department of Hepatobiliary Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Department of Hepatobiliary Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032401979","display_name":"Udai Banerji","orcid":"https://orcid.org/0000-0003-1503-3123","observed_orcids":["https://orcid.org/0000-0003-1503-3123"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Udai Banerji","raw_affiliation_strings":["9Clinical Pharmacology and Trials, The Institute of Cancer Research and The Royal Marsden, London, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-1503-3123","affiliations":[{"raw_affiliation_string":"9Clinical Pharmacology and Trials, The Institute of Cancer Research and The Royal Marsden, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053619368","display_name":"Raghav Sundar","orcid":"https://orcid.org/0000-0001-9423-1368","observed_orcids":["https://orcid.org/0000-0001-9423-1368"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210150261","display_name":"National University Health System","ror":"https://ror.org/05tjjsh18","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596","https://openalex.org/I4210150261"]}],"countries":["GB","SG"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Raghav Sundar","raw_affiliation_strings":["10Department of Haematology-Oncology, The Institute of Cancer Research and The Royal Marsden, London, United Kingdom","11National University Health System, Singapore"],"raw_orcid":"https://orcid.org/0000-0001-9423-1368","affiliations":[{"raw_affiliation_string":"10Department of Haematology-Oncology, The Institute of Cancer Research and The Royal Marsden, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]},{"raw_affiliation_string":"11National University Health System, Singapore","institution_ids":["https://openalex.org/I4210150261"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073872895","display_name":"Shuichi Ohkubo","orcid":"https://orcid.org/0000-0001-9554-4534","observed_orcids":["https://orcid.org/0000-0001-9554-4534"]},"institutions":[{"id":"https://openalex.org/I4210120269","display_name":"Taiho Pharmaceutical (Japan)","ror":"https://ror.org/02v50dx14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210120269"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shuichi Ohkubo","raw_affiliation_strings":["12Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tokyo, Japan","institution_ids":["https://openalex.org/I4210120269"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047182400","display_name":"Elizabeth Martine Calleja","orcid":"https://orcid.org/0009-0005-7163-9922","observed_orcids":["https://orcid.org/0009-0005-7163-9922"]},"institutions":[{"id":"https://openalex.org/I4210124059","display_name":"Taiho Oncology (United States)","ror":"https://ror.org/02z43nn16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124059"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elizabeth M. Calleja","raw_affiliation_strings":["13Taiho Oncology, Inc., Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13Taiho Oncology, Inc., Princeton, New Jersey","institution_ids":["https://openalex.org/I4210124059"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078287634","display_name":"Makoto Nishio","orcid":"https://orcid.org/0000-0003-4969-4165","observed_orcids":["https://orcid.org/0000-0003-4969-4165"]},"institutions":[{"id":"https://openalex.org/I4210137039","display_name":"The Cancer Institute Hospital","ror":"https://ror.org/03md8p445","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137039"]},{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Makoto Nishio","raw_affiliation_strings":["5Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0000-0003-4969-4165","affiliations":[{"raw_affiliation_string":"5Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan","institution_ids":["https://openalex.org/I4210137039","https://openalex.org/I42570316"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.2511,"has_fulltext":false,"cited_by_count":96,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.93993457,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"18","issue":"3","first_page":"531","last_page":"540"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10958","display_name":"Ultrasound and Hyperthermia Applications","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hsp90-inhibitors","display_name":"Hsp90 inhibitors","score":0.9120000004768372},{"id":"https://openalex.org/keywords/oral-chemotherapy","display_name":"oral chemotherapy","score":0.5299999713897705},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.9319999814033508},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.949999988079071},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8759999871253967},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9860000014305115},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.46399998664855957},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.8259999752044678},{"id":"https://openalex.org/keywords/gastrointestinal-stromal-tumor","display_name":"gastrointestinal stromal tumor","score":0.8849999904632568},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6970000267028809},{"id":"https://openalex.org/keywords/accelerated-titration","display_name":"accelerated titration","score":0.4690000116825104},{"id":"https://openalex.org/keywords/eye-diseases","display_name":"eye diseases","score":0.39500001072883606}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7535568475723267},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6886774301528931},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6819955110549927},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6336007118225098},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5480327010154724},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4465941786766052},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.44611552357673645},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.44074711203575134},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43001413345336914},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42419326305389404},{"id":"https://openalex.org/C2775922572","wikidata":"https://www.wikidata.org/wiki/Q83567","display_name":"GiST","level":3,"score":0.41487962007522583},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3797509968280792},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3412930369377136},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.23274174332618713},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.15787440538406372}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018841","descriptor_name":"HSP90 Heat-Shock Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018841","descriptor_name":"HSP90 Heat-Shock Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046152","descriptor_name":"Gastrointestinal Stromal Tumors","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D046152","descriptor_name":"Gastrointestinal Stromal Tumors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D046152","descriptor_name":"Gastrointestinal Stromal Tumors","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-18-0831","doi":"https://doi.org/10.1158/1535-7163.mct-18-0831","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-18-0831","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:30679388","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30679388","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G2295178940","display_name":"Translational proteomics to understand and overcome drug resistance to targeted anticancer drugs in KRAS and PIK3CA driven cancers","funder_award_id":"RP-2016-07-028","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G3601372966","display_name":null,"funder_award_id":"11566","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G380587149","display_name":"Association of immune responses with racial differences of cancer development","funder_award_id":"17H06162","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G662952953","display_name":null,"funder_award_id":"22897","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"}],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1980282046","https://openalex.org/W1988675578","https://openalex.org/W1997041432","https://openalex.org/W2000929246","https://openalex.org/W2022531767","https://openalex.org/W2028586466","https://openalex.org/W2030379493","https://openalex.org/W2045604189","https://openalex.org/W2060902443","https://openalex.org/W2062428732","https://openalex.org/W2073761249","https://openalex.org/W2080053266","https://openalex.org/W2085961273","https://openalex.org/W2090940245","https://openalex.org/W2091495423","https://openalex.org/W2097382830","https://openalex.org/W2098070947","https://openalex.org/W2100214216","https://openalex.org/W2107270715","https://openalex.org/W2111490539","https://openalex.org/W2112417555","https://openalex.org/W2113523455","https://openalex.org/W2125007784","https://openalex.org/W2130986759","https://openalex.org/W2151252337","https://openalex.org/W2165563508","https://openalex.org/W2180914302","https://openalex.org/W2286032795","https://openalex.org/W2308064764","https://openalex.org/W2508409977","https://openalex.org/W2592597503","https://openalex.org/W2606824156"],"related_works":["https://openalex.org/W2662567642","https://openalex.org/W2397217268","https://openalex.org/W3203244025","https://openalex.org/W3032685799","https://openalex.org/W2165563508","https://openalex.org/W3150548245","https://openalex.org/W2060177103","https://openalex.org/W3156818189","https://openalex.org/W2979275250","https://openalex.org/W2334958964"],"abstract_inverted_index":{"HSP90":[0,160,223,236],"is":[1,226],"involved":[2],"in":[3,57,96,167,233,243],"stability":[4],"and":[5,21,70,86,98,111,151,185,195],"function":[6],"of":[7,25,35,120,179,221],"cancer-related":[8],"proteins.":[9],"This":[10,225],"study":[11],"was":[12,103,124],"conducted":[13],"to":[14,67,105,173],"define":[15],"the":[16,75,78,99,117,168,235],"MTD,":[17],"safety,":[18],"pharmacokinetics,":[19],"pharmacodynamics,":[20],"preliminary":[22,240],"antitumor":[23,216,241],"efficacy":[24,242],"TAS-116,":[26],"a":[27,63,87,204,227,230],"novel":[28],"class,":[29],"orally":[30,44],"available,":[31],"highly":[32],"selective":[33],"inhibitor":[34,237],"HSP90.":[36],"Patients":[37],"with":[38,159,165,183,190,198,214,245,251],"advanced":[39,246],"solid":[40,247],"tumors":[41],"received":[42],"TAS-116":[43,123,166,180,208,238],"once":[45],"daily":[46],"(QD,":[47],"step":[48,55,61,121],"1)":[49],"or":[50],"every":[51],"other":[52],"day":[53],"(QOD,":[54],"2)":[56],"21-day":[58],"cycles.":[59],"Each":[60],"comprised":[62],"dose":[64,79],"escalation":[65,80],"phase":[66,73,119],"determine":[68],"MTD":[69,102],"an":[71,82,210],"expansion":[72,118,169],"at":[74],"MTD.":[76],"In":[77,116],"phase,":[81],"accelerated":[83],"dose-titration":[84],"design":[85,89],"\u201c3+3\u201d":[88],"were":[90,94,171],"used.":[91],"Sixty-one":[92],"patients":[93,189,244],"enrolled":[95],"Japan":[97],"United":[100],"Kingdom.":[101],"determined":[104],"be":[106],"107.5":[107],"mg/m2/day":[108,113],"for":[109,114],"QD,":[110],"210.7":[112],"QOD.":[115],"1,":[122],"administered":[125],"5":[126],"days":[127,129],"on/2":[128],"off":[130],"per":[131],"week":[132],"(QD":[133],"\u00d7":[134],"5).":[135],"The":[136,176],"most":[137],"common":[138],"treatment-related":[139],"adverse":[140],"events":[141],"included":[142],"gastrointestinal":[143,199],"disorders,":[144],"creatinine":[145],"increases,":[146,148,150],"AST":[147],"ALT":[149],"eye":[152],"disorders.":[153],"Eye":[154],"disorders":[155],"have":[156],"been":[157],"reported":[158],"inhibitors;":[161],"however,":[162],"those":[163,250],"observed":[164],"phases":[170],"limited":[172],"grade":[174],"1.":[175],"systemic":[177],"exposure":[178],"increased":[181],"dose-proportionally":[182],"QD":[184],"QOD":[186],"regimens.":[187],"Two":[188],"non\u2013small":[191],"cell":[192],"lung":[193],"cancer":[194],"one":[196],"patient":[197],"stromal":[200],"tumor":[201],"(GIST)":[202],"achieved":[203],"confirmed":[205],"partial":[206],"response.":[207],"had":[209],"acceptable":[211],"safety":[212],"profile":[213],"some":[215],"activity,":[217],"supporting":[218],"further":[219],"development":[220],"this":[222],"inhibitor.":[224],"result":[228],"from":[229],"first-in-human":[231],"study,":[232],"which":[234],"demonstrated":[239],"tumors,":[248],"including":[249],"heavily":[252],"pretreated":[253],"GIST.":[254]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2911547717","counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":22},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2019-02-21T00:00:00"}
